Prot #MT-08: A Post-Market, Prospective, Randomized, Controlled, Multicenter International Study to Assess the Safety of the Temporarily Implanted Nitinol Device (iTind) Compared to the UroLift® System in Subjects with Symptomatic Benign Prostatic Hyperpl

Project: Research project

Project Details

StatusActive
Effective start/end date5/21/245/21/27

Funding

  • Olympus Corporation of the Americas (Prot #MT-08)